Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092271570> ?p ?o ?g. }
- W3092271570 endingPage "18888" @default.
- W3092271570 startingPage "18878" @default.
- W3092271570 abstract "In this retrospective study we assessed the efficacy and safety of tocilizumab in patients with critical or severe coronavirus disease 2019 (COVID-19). We enrolled 181 patients admitted to Huoshenshan Hospital (Wuhan, China) with confirmed COVID-19 between January 2020 and February 2020. Ninety-two patients were treated with tocilizumab, and 89 patients were treated conventionally. We analyzed the clinical manifestations, changes in CT scan images, and laboratory tests before and after tocilizumab treatment, and compared these results with the conventionally treated group. A significant reduction in the level of C-reactive protein was observed 1 week after tocilizumab administration. In some cases this meant the end of the IL-6-related cytokine storm. In addition, tocilizumab relieved fever, cough, and shortness of breath with no reported adverse drug reactions. These findings suggest tocilizumab improves clinical outcomes and is effective for treatment of patients with critical or severe COVID-19. However, future clinical trials are needed to better understand the impact of tocilizumab interference with IL-6 and provide a therapeutic strategy for treatment of COVID-19." @default.
- W3092271570 created "2020-10-15" @default.
- W3092271570 creator A5000492550 @default.
- W3092271570 creator A5002581722 @default.
- W3092271570 creator A5002603813 @default.
- W3092271570 creator A5004681856 @default.
- W3092271570 creator A5016028341 @default.
- W3092271570 creator A5017674187 @default.
- W3092271570 creator A5021407600 @default.
- W3092271570 creator A5026855778 @default.
- W3092271570 creator A5029981096 @default.
- W3092271570 creator A5044922907 @default.
- W3092271570 creator A5048431529 @default.
- W3092271570 creator A5060228349 @default.
- W3092271570 creator A5074053744 @default.
- W3092271570 creator A5079104533 @default.
- W3092271570 creator A5079492665 @default.
- W3092271570 creator A5085215903 @default.
- W3092271570 creator A5089935282 @default.
- W3092271570 date "2020-10-08" @default.
- W3092271570 modified "2023-10-16" @default.
- W3092271570 title "Efficacy and safety of tocilizumab in COVID-19 patients" @default.
- W3092271570 cites W1969791558 @default.
- W3092271570 cites W1980869604 @default.
- W3092271570 cites W1984742686 @default.
- W3092271570 cites W1989324767 @default.
- W3092271570 cites W1990059132 @default.
- W3092271570 cites W1993310990 @default.
- W3092271570 cites W2023761225 @default.
- W3092271570 cites W2024886564 @default.
- W3092271570 cites W2053365125 @default.
- W3092271570 cites W2063634757 @default.
- W3092271570 cites W2070463916 @default.
- W3092271570 cites W2102207725 @default.
- W3092271570 cites W2104030082 @default.
- W3092271570 cites W2120852203 @default.
- W3092271570 cites W2145441153 @default.
- W3092271570 cites W2306794997 @default.
- W3092271570 cites W2589423801 @default.
- W3092271570 cites W2775086803 @default.
- W3092271570 cites W2790127336 @default.
- W3092271570 cites W2936452886 @default.
- W3092271570 cites W2952225287 @default.
- W3092271570 cites W2954197984 @default.
- W3092271570 cites W3001118548 @default.
- W3092271570 cites W3001456238 @default.
- W3092271570 cites W3007201727 @default.
- W3092271570 cites W3008028633 @default.
- W3092271570 cites W3008090866 @default.
- W3092271570 cites W3009859788 @default.
- W3092271570 cites W3012706084 @default.
- W3092271570 cites W3014001472 @default.
- W3092271570 cites W3014050022 @default.
- W3092271570 cites W3014306106 @default.
- W3092271570 cites W3014333693 @default.
- W3092271570 cites W3017287557 @default.
- W3092271570 cites W3022970339 @default.
- W3092271570 cites W3032543466 @default.
- W3092271570 cites W3165656738 @default.
- W3092271570 doi "https://doi.org/10.18632/aging.103988" @default.
- W3092271570 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7732317" @default.
- W3092271570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33031060" @default.
- W3092271570 hasPublicationYear "2020" @default.
- W3092271570 type Work @default.
- W3092271570 sameAs 3092271570 @default.
- W3092271570 citedByCount "11" @default.
- W3092271570 countsByYear W30922715702021 @default.
- W3092271570 countsByYear W30922715702022 @default.
- W3092271570 countsByYear W30922715702023 @default.
- W3092271570 crossrefType "journal-article" @default.
- W3092271570 hasAuthorship W3092271570A5000492550 @default.
- W3092271570 hasAuthorship W3092271570A5002581722 @default.
- W3092271570 hasAuthorship W3092271570A5002603813 @default.
- W3092271570 hasAuthorship W3092271570A5004681856 @default.
- W3092271570 hasAuthorship W3092271570A5016028341 @default.
- W3092271570 hasAuthorship W3092271570A5017674187 @default.
- W3092271570 hasAuthorship W3092271570A5021407600 @default.
- W3092271570 hasAuthorship W3092271570A5026855778 @default.
- W3092271570 hasAuthorship W3092271570A5029981096 @default.
- W3092271570 hasAuthorship W3092271570A5044922907 @default.
- W3092271570 hasAuthorship W3092271570A5048431529 @default.
- W3092271570 hasAuthorship W3092271570A5060228349 @default.
- W3092271570 hasAuthorship W3092271570A5074053744 @default.
- W3092271570 hasAuthorship W3092271570A5079104533 @default.
- W3092271570 hasAuthorship W3092271570A5079492665 @default.
- W3092271570 hasAuthorship W3092271570A5085215903 @default.
- W3092271570 hasAuthorship W3092271570A5089935282 @default.
- W3092271570 hasBestOaLocation W30922715701 @default.
- W3092271570 hasConcept C11988809 @default.
- W3092271570 hasConcept C126322002 @default.
- W3092271570 hasConcept C197934379 @default.
- W3092271570 hasConcept C2777178219 @default.
- W3092271570 hasConcept C2778690821 @default.
- W3092271570 hasConcept C2779134260 @default.
- W3092271570 hasConcept C2779559532 @default.
- W3092271570 hasConcept C2780850621 @default.
- W3092271570 hasConcept C3008058167 @default.
- W3092271570 hasConcept C524204448 @default.